SavedAdd your journal

Journals / Hacettepe Journal of Biology and Chemistry / 2014 / Cilt: 42 - Sayı: 4

Some Biomarkers of Kidney Diseases

Böbrek Hastalıkları için Bazı Biyobelirteçler

Aykut Arif TOPÇU
Pages
557–562
Publication Date
2014-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, some biomarkers were represented and supported by research articles for diagnostic chronic kidney disease with acute kidney injury.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kidneys are one of the indispensible organs of our body especially for hemostasis and responsible for regu- lates arterial pressure, blood filter, water balance, gluconeogenesis etc.
📊
Key Findings & Data:Renal diseases have been divided acute kidney injury and chronic kidney diseases according to glomerular filtration rate.
💡
Conclusion & Impact:In this review, some biomarkers were represented and supported by research articles for diagnostic chronic kidney disease with acute kidney injury.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Böbrek hastalıkları · biyobelirteçler · BTP

Abstract

Kidneys are one of the indispensible organs of our body especially for hemostasis and responsible for regu- lates arterial pressure, blood filter, water balance, gluconeogenesis etc. Renal diseases have been divided acute kidney injury and chronic kidney diseases according to glomerular filtration rate. At last stage of glome- rular filtration rate 5. stage is not only harmful but also irreversible stage, for overcoming this stage kidney transplant and dialysis are important medical cares. Nowadays biomarkers are useful indicator for diagnostic, therapy and monitoring of diseases control. In this review, some biomarkers were represented and supported by research articles for diagnostic chronic kidney disease with acute kidney injury.

Özet

S unulan bu Özet: Böbrekler vücudumuz için; özellikle hemostaz ve atardamar basıncının düzenlenmesi, kanın temizlenmesi, su dengesi ve glukoneogenez gibi görevlerden sorumlu olan hayati organlardan birisidir. Böbrek hastalıkları glomerüler filtrasyon oranına göre; akut böbrek hasarları ve kronik böbrek hastalıkları olarak 2 gruba ayrılmaktadır. Glomerüler filtrasyon oranının son evresi 5. evre zararlı olmasının yanında geri dönüşünü olmayan özellikte olup, böbrek nakli ve diyaliz önemli tedavi yöntemleridir. Günümüze biyobelirteçler hastaların teşhisinde, tedavisinde ve hastalığın seyrini takip etmede kullanılırlar. Bu derlemede kronik böbrek hastalıklarını ile akut böbrek hasarlarını teşhiş etmek için bazı biyobelirteçler araştırma makaleleri ile birlikte sunulmuştur

🔖

Cite This Article

TOPÇU, A. A. (2014). Some Biomarkers of Kidney Diseases. Hacettepe Journal of Biology and Chemistry, Cilt: 42 - Sayı: 4, 557–562. https://ajindex.com/articles/256208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. A. Stein, A. Wild, Kidney failure explained, Class Publishing, London, (2002) 1
  2. Brenner: Brenner and Rector’s The Kidney, 8th Ed, Saunders, Elsevier, (2007) 25
  3. Tietz, Fundamentals of Clinical Chemistry, 6th, Saunders, Elsevier (2008) 632
  4. C.A. Guyton, E.J. Hall, Tıbbi Fizyoloji, 10. Edisyon, Yüce Yayınları&Nobel Tıp Kitabevleri (2001) 281
  5. C.D. Eaton, P.J Pooler, Vander’s Renal Physiology, 7th Edition, The McGraw-Hill Companies, (2009) 3
  6. R. Croft, J. Moore, Renal failure and its treatment, Anesthesia and Intensive Care Medicine, 13 (2012) 336
  7. S,A. Levery, J. Coresh, Chronic kidney disease, Lancet, 379 (2012) 165 8. D.P. Evans, W.M. Taal, Epidemiology and causes of chronic kidney disease, Chronic Renal Failure, Medicine, 39 (2011) 402
  8. C. Tomson, P. Bailey, Management of chronic kidney disease, Medicine 39 (2011) 407
  9. S. Jayasundera, R. Macnab, Laboratory tests of renal function, Anasthesia and Intensive Care Medicine, 13 (2012) 328
  10. E. Lamb, Assessment of kidney functions in adults, Laboratory Investigations, Medicine, 35 (2007)
  11. L.E. Schiffrin, L.M.Lipman, F.E.J. Mann, Chronic Kidney Disease Effects on the Cardiovascular System, Circulation, 116 (2007) 85
  12. A.J. Vassalotti, A.L. Stevens, S.A Levey, Testing for Chronic Kidney Disease: A Position Statement From the National Kidney Foundation, American Journal of Kidney Diseases, 50 (2007) 169
  13. A. Tin, C.B. Astor, E. Bperwinkle, J. Coresh, J. and H.W. Linda Kao,Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans, Nephrol Dial Transplant, 28 (2013) 1497
  14. C. Donadio, A. Lucchesi, M. Ardini, E. Donadio, R. Giordani, Serum levels of beta-trace protein and glomerular filtration rate-preliminary results, Journal of Pharmaceutical and Biomedical Analysis, 32 (2003) 1099
  15. F. Priem, H. Althaus, M. Birnbaum, P. Sinha, S.H. Condradt, and K. Jung, b-Trace Protein in Serum: A New Marker of Glomerular Filtration Rate in the Creatinine-Blind Range, Clinical Chemistry, 45 (1999) 567
  16. A. Hoffmann, M. Nimtz, and S.H. Conradt, Molecular characterization of P-trace protein in human serum and urine: a potential diagnostic marker for renal diseases, Glycoblology, 7 (1997) 499
  17. F. Waanders, V.M.M. Timmeren, A.C. Stegeman, JL.S. Bakker, and V.H. Goor, Kidney injury molecule-1 in renal disease, J. Pathol, 220 (2010) 7
  18. T. Ichimura, V.J. Bonventre, V. Bailly, H. Wei, A.C. Hession, L.R. Ca